MediaTek started shipping SoC solutions with integrated 4G LTE baseband in volume in the second half of 2014, which was later than Qualcomm, which had been shipping SoCs with integrated 4G for some time,  which was likely to impact MediaTek as Chinese telecom providers such as China Mobile and carriers in other countries push and subsidize LTE technology.  Although MediaTek's MT6290 stand-alone 4G baseband combined with its MT6582 or MT6592 SoCs is less profitable for MediaTek than a single-chip 4G solution would be, as of mid-2014 they have been adopted in some models by large manufacturers.   However, the first generation of new affordable 4G smartphone models from large MediaTek clients such as Alcatel One Touch and ZTE use Qualcomm's Snapdragon 400 and 410 platforms with integrated 4G baseband.   MediaTek has indicated that chips with 4G were expected to make up 20% of shipments in Q4 2014, with a significant increase expected for 2015,  which will also see improvements to its product mix as new 4G chips allow it to target higher market segments. 
Injectable steroids are injected into muscle tissue, not into the veins. They are slowly released from the muscles into the rest of the body, and may be detectable for months after last use. Injectable steroids can be oil-based or water-based. Injectable anabolic steroids which are oil-based have longer half-life than water-based steroids. Both steroid types have much longer half-lives than oral anabolic steroids. And this is proving to be a drawback for injectables as they have high probability of being detected in drug screening since their clearance times tend to be longer than orals. Athletes resolve this problem by using injectable testosterone early in the cycle then switch to orals when approaching the end of the cycle and drug testing is imminent.